Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV

Sarah T. Wilkinson, Diane R. Fernandez, Shawn P. Murphy, Rita M. Braziel, Elias Campo, Wing C. Chan, Jan Delabie, Randy D. Gascoyne, Louis M. Staudt, Elaine S. Jaffe, Andreas Rosenwald, Lisa M. Rimsza

Research output: Contribution to journalLetter

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)1875-1878
Number of pages4
JournalLeukemia and Lymphoma
Volume50
Issue number11
DOIs
StatePublished - Nov 1 2009

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Wilkinson, S. T., Fernandez, D. R., Murphy, S. P., Braziel, R. M., Campo, E., Chan, W. C., Delabie, J., Gascoyne, R. D., Staudt, L. M., Jaffe, E. S., Rosenwald, A., & Rimsza, L. M. (2009). Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV. Leukemia and Lymphoma, 50(11), 1875-1878. https://doi.org/10.3109/10428190903297531